FDA
Juno Therapeutics Cancer Trial Stops After 3 Deaths, But Other Gene Therapy Trials Continue
The FDA put a stop to a CAR-T cell therapy trial on leukemia sufferers after the deaths of three patients. Juno Therapeutics, the company behind the clinical trial, says it knows what caused the deaths and wants the trial to proceed with modifications.
Latest Research Articles
Hepatitis C Update: FDA Approves Gilead's New Drug to Treat All Form of Hepatitis C
Zika Update: First Zika Vaccine Ready for Human Trial
National Frozen Food Corporation Issues Voluntary Recall on Frozen Peas Over Potential Listeria Contamination
Alert! This Popular Snack Brand Was Recalled Due to Peanut Allergen
Whole Foods Receives FDA Warning Over Unsanitary Conditions, Evidence of Listeria
FDA Warning: High Doses of Anti-Diarrhea Drugs Could Lead to Serious Heart Problems
Swallowing This Balloon Can Make You Lose Weight, Scientists Say
Watch Out For These 5 Key Changes on Food Labels
Cystic Fibrosis: Drug Treatment Offers New Hope for Patients
Modified Mosquitoes May March on Florida This Spring, But Are They Welcome? [EXCLUSIVE]
Approved Drug May Preserve Brain Function After Stroke
Treating Your Acne Could Kill You
MOST POPULAR
-
Mount Rainier's Volcanic Activity Closely Watched by Scientists
-
How Earthquakes 'Ignite': Hidden Mechanism Discovered in New Study
-
Volcanic Eruptions Linked to Neolithic Sun Stone Sacrifices in Denmark
-
Homo Erectus Mastered Desert Survival 1.2 Million Years Ago
-
Weak Spot in Earth's Magnetic Field Raises Concerns for Humanity's Future
